Staff Reporter
Published:
In vitro diagnostics to be valued at $141.9b by 2029
Point-of-care testing is gaining popularity over traditional hospital and clinic diagnostics.
The in vitro diagnostics market is projected to reach $141.9b by 2029 at a compound annual growth rate of 8.4%, according to BCC Research.
The sector’s expansion is attributed to the increasing ageing population and the rise of chronic diseases, such as diabetes and heart conditions.
Point-of-care testing is gaining popularity over traditional hospital and clinic diagnostics, with demand surging post-pandemic.
Meanwhile, artificial intelligence integration is improving the accuracy and speed of disease detection, further driving market growth.
Read Here
Advertise
Sign Up
